FTRK logo

FTRKFast Track Group.

$0.4557
$0.0548
(10.74%)
Today
Closed $0.4552
$0.0005
(0.11%)
After Hours
Updated: 05:38 PM EDT
Mkt Cap$11.12M
Vol16,167.00
News
all
press releases
Elon Musk's SpaceX Won't Get A Fast Track To The S&P 500 As Index Provider Keeps Rules Unchanged
S&P Dow Jones Indices rejected changes to entry requirements for its indexes, hindering SpaceX's quick entry into S&P 500.read more...
Benzinga
News Placeholder
More News
News Placeholder
What's Pushing Moderna Stock Higher Today?
Moderna (NASDAQ:MRNA) shares are moving higher on Monday after the company won FDA Fast Track status for an oncology program.read more...
Benzinga
News Placeholder
SpaceX IPO Countdown Accelerates Musk's Rocket Juggernaut Fast Tracks Vesting
SpaceX has notified its employees that the vesting date for shares is going to occur this month instead of in May.read more...
Benzinga
News Placeholder
Why Cocrystal Pharma Shares Are Cooling Off Monday?
COCP stock is trading lower Monday morning. Learn why Cocrystal Pharma is seeing a pullback after receiving FDA Fast Track designation for CDI-988.read more...
Benzinga
News Placeholder
Cocrystal Pharma Shares Soar After FDA Grants Fast Track Status To CDI-988
Cocrystal Pharma Inc. (NASDAQ:COCP) shares are trading higher Thursday after it received Fast Track designation from the FDA for its CDI-988.read more...
Benzinga
News Placeholder
NASA to Spend $20 Billion to Fast Track New Moon Base
NASA to Spend $20 Billion to Fast Track New Moon Base...
Bloomberg Markets and Finance-YouTube
News Placeholder
Precision BioSciences Gets FDAT Fast Track Status For PBGENE-DMD
(RTTNews) - Precision BioSciences said the U.S. Food and Drug Administration has granted Fast Track designation to its investigational therapy PBGENE-DMD for the treatment of Duchenne muscular...
Nasdaq News: Markets
News Placeholder
Aktis Oncology Details Radiopharma Expansion, Fast Track Win for AKY-1189 at TD Cowen Conference
Aktis Oncology (NASDAQ:AKTS) used a presentation at TD Cowen's 46th Annual Healthcare Conference to outline its strategy to broaden the reach of targeted radiopharmaceutical therapy beyond today's...
MarketBeat
News Placeholder
Canada Announces Plan To Recruit Foreign Soldiers For Fast Track Immigration
Canada Announces Plan To Recruit Foreign Soldiers For Fast Track Immigration It's a common theme throughout history - When governments go authoritarian, they often hire foreign soldiers in order to...
Zero Hedge
News Placeholder
Cullinan Therapeutics Tees Up Catalyst-Heavy 2026 With Q2 CLN-978 Data and AML Fast Track Momentum
Cullinan Therapeutics (NASDAQ:CGEM) expects 2026 to be a catalyst-heavy year across its pipeline, led by two high-priority T-cell engager programs in autoimmune disease and acute myeloid leukemia...
MarketBeat
<
1
2
...
>

Advertisement|Remove ads.